STOCK TITAN

SONENDO (SONX) Stock News, Nov 2021-Mar 2022

SONX OTC

Sonendo, Inc. reports developments as a commercial-stage dental technology company built around the GentleWave® System for root canal therapy. The company develops and manufactures a platform that uses procedure fluid optimization, broad-spectrum acoustic energy and fluid dynamics to clean and disinfect microscopic spaces within teeth while preserving tooth structure.

SONX news commonly covers quarterly and annual results, console sales, procedure-related consumables and service revenue, gross margin, operating expense reductions and cash-flow guidance. Company updates also address commercial execution, liquidity actions such as private placements and credit facility amendments, leadership changes, and the completed divestiture of the TDO practice management software segment.

Rhea-AI Summary

Sonendo, a dental technology company traded as NYSE:SONX, is set to present at the Piper Sandler Dental Day on March 29 at 12:00 p.m. ET. CEO Bjarne Bergheim and CFO Michael Watts will discuss the GentleWave® System, which treats tooth decay with minimal invasiveness. This innovative system improves clinical outcomes significantly compared to traditional methods, leading to rapid healing and reduced post-operative pain. Additionally, Sonendo owns TDO® Software, enhancing dental practice management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.51%
Tags
conferences
-
Rhea-AI Summary

Sonendo, a leading dental technology company, reported its financial results for Q4 and the full year 2021. Total revenue for Q4 reached $9.9 million, a 14% increase year-over-year, and $33.2 million for the entire year, marking a 42% growth from 2020. The company achieved a gross margin of 25% in Q4, up from 20% in Q4 2020. Despite a net loss of $13.7 million in Q4, the company raised $84 million during its IPO. For 2022, Sonendo expects to generate between $40 million and $43 million in revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-15.88%
Tags
-
Rhea-AI Summary

Sonendo, Inc. (NYSE: SONX) has reached a significant milestone of 800,000 GentleWave patient procedures, just five months after hitting 700,000. This achievement indicates increasing adoption of the GentleWave System, a less invasive and less painful alternative to traditional root canal therapy. The milestone was celebrated by Dr. Mark Germack, who treated the 800,000th patient. Additionally, Sonendo announced investment in Area Practice Consultants to aid onboarding and practice growth for endodontists, reflecting the company's commitment to improving treatment efficacy and customer support.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
30.88%
Tags
none
Rhea-AI Summary

Sonendo, Inc. (NYSE: SONX), a dental technology firm, will report its financial results for Q4 and the full year 2021 after market close on March 23, 2022. A conference call will follow at 1:30 PM PT / 4:30 PM ET to discuss these results. Investors can access the call by dialing (844) 200-6205 for domestic or (929) 526-1599 for international listeners, using access code: 450135. Live audio webcasts will also be available on the company's investor website.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.68%
Tags
conferences earnings
-
Rhea-AI Summary

Sonendo, Inc. (NYSE: SONX) announced preliminary revenue results for Q4 and full-year 2021. For Q4, revenue is estimated between $9.7 million and $9.9 million, with product revenue expected between $7.5 million and $7.7 million. Full-year revenue is anticipated to be $33.0 million to $33.2 million, marking a growth of 41% to 42% compared to $23.4 million in 2020. Sonendo highlights the effective expansion of its commercial team and the growing adoption of its GentleWave® System as key achievements.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
19.68%
Tags
-
Rhea-AI Summary

Sonendo, a leading dental technology firm, reported a 29% increase in total revenue for Q3 2021, totaling $7.9 million.

The GentleWave console revenue rose 44% to $1.8 million, while procedure instrument revenue climbed 30% to $3.7 million. Software revenue grew 17% to $1.7 million. The company completed its IPO on November 2, raising approximately $84 million.

For 2021, Sonendo projects total revenue between $32 million and $32.5 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.53%
Tags
Rhea-AI Summary

Sonendo (NYSE: SONX) has appointed Raj Pudipeddi to its Board of Directors. Pudipeddi, currently an executive at Align Technology, brings 27 years of experience in brand-building and consumer products. His background includes leadership roles at Procter & Gamble and Bharti Airtel. Sonendo's president and CEO, Bjarne Bergheim, highlighted Pudipeddi's expertise in driving growth and innovation in transforming root canal therapy through the GentleWave System. This addition follows the recent announcement of three other new board members.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.26%
Tags
management
-
Rhea-AI Summary

Sonendo, a dental technology leader, will release its third-quarter financial results after market close on December 9, 2021. A conference call will be held at 1:30 p.m. PT to discuss these results. The company is known for its GentleWave System, which enhances root canal treatments by effectively cleaning and disinfecting teeth, reducing post-operative discomfort, and improving clinical outcomes. Sonendo also owns TDO Software, which streamlines dental practice management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
conferences earnings
-
Rhea-AI Summary

Sonendo, Inc. (NYSE: SONX) has appointed Alma Salazar as the Associate Vice President of Professional and Consumer Marketing. Salazar brings extensive experience from Align Technology, where she led successful marketing campaigns. With approximately 17 million root canal procedures performed annually in the U.S. and Canada, Sonendo aims to enhance patient education about its GentleWave® System, which offers innovative alternatives to traditional methods. Salazar's expertise is expected to help Sonendo strengthen its market presence and improve patient outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10%
Tags
none
Rhea-AI Summary

Sonendo, Inc. (NYSE: SONX) has successfully treated over 700,000 patients using its innovative GentleWave® System, marking a significant milestone shortly after its IPO on October 29, 2021. The GentleWave System offers a less invasive alternative to traditional root canal therapy, utilizing advanced technology to enhance cleaning and disinfection within teeth while preserving tooth structure. Clinical outcomes are notably improved, with rapid healing rates and minimal post-operative pain reported. This achievement underscores the company's commitment to enhancing dental care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.85%
Tags
none

FAQ

What is the current stock price of SONENDO (SONX)?

SONENDO (SONX) last closed at $1.28.

What is the market cap of SONENDO (SONX)?

The market cap of SONENDO (SONX) is approximately $6.1M.